38. DiSanto, J.P., W. Müller, D. Guy-Grand, A. Fischer, and K. Rajewsky. 1995. Lymphoid development in mice with a tar- geted deletion of the interleukin-2 receptor g chain. Proc. Natl. Acad. Sci. USA. 92:377–381. 39. Cao, X., E.W. Shores, J. Hu-Li, M.R. Anver, B.L. Kelsall, S.M. Russell, J. Drago, M. Noguchi, A. Grinberg, E.T. Bloom, et al. 1995. Defective lymphoid development in mice lacking expression of the common cytokine receptor g chain. Immunity. 2:223–238. 40. Nosaka, T., J.M. van Deursen, R.A. Tripp, W.E. Thier- felder, B.A. Witthuhn, A.P. McMickle, P.C. Doherty, G.C. Grosveld, and J.N. Ihle. 1995. Defective lymphoid develop- ment in mice lacking Jak3. Science. 270:800–802. 41. Thomis, D.C., C.B. Gurniak, E. Tivol, A.H. Sharpe, and L.J. Berg. 1995. Defects in B lymphocyte maturation and T lym- phocyte activation in mice lacking Jak3. Science. 270:794– 797. 42. Park, S.Y., K. Saijo, T. Takahashi, M. Osawa, H. Arase, N. Hirayama, K. Miyake, H. Nakauchi, T. Shirasawa, and T. Saito. 1995. Developmental defects of lymphoid cells in Jak3 kinase-deficient mice. Immunity. 3:771–782. 43. Carson, W.E., J.G. Giri, M.J. Lindemann, M.L. Linett, M. Ahdieh, R. Paxton, D. Anderson, J. Eisenmann, K. Grab- stein, and M.A. Caligiuri. 1994. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via compo- nents of the IL-2 receptor. J. Exp. Med. 180:1395–1403. 44. Cavazzana-Calvo, M., S. Hacein-Bey, G. de Saint Basile, C. de Coene, F. Selz, F. Le Deist, and A. Fischer. 1996. Role of interleukin-2 (IL-2), IL-7, and IL-15 in natural killer cell dif- ferentiation from cord blood hematopoietic progenitor cells and from gc transduced severe combined immunodeficiency X1 bone marrow cells. Blood. 88:3901–3909. 45. Leclercq, G., V. Debacker, M. de Smedt, and J. Plum. 1996. Differential effects of interleukin-15 and interleukin-2 on the differentiation of bipotential T/natural killer progenitor cells. J. Exp. Med. 184:325–336. 46. Puzanov, I.J., M. Bennett, and V. Kumar. 1996. IL-15 can substitute for the marrow microenvironment in the differen- tiation of natural killer cells. J. Immunol. 157:4282–4285. 47. Ogasawara, K., S. Hida, N. Azimi, Y. Tagaya, T. Sato, T. Yokochi-Fukuda, T.A. Waldmann, T. Taniguchi, and S. Taki. 1998. Requirement for IRF-1 in the microenviron- ment supporting development of natural killer cells. Nature. 391:700–703. 48. Lin, J.-X., N. Bhat, S. John, W.S. Queale, and W.J. Leonard. 1993. Characterization of the human interleukin-2 receptor b chain gene promoter: regulation of promoter activity by ets gene products. Mol. Cell. Biol. 13:6201–6210. 49. Lin, J.X., and W.J. Leonard. 1997. The immediate-early gene product Egr-1 regulates the human interleukin-2 receptor b-chain promoter through non-canonical Egr and Sp1 bind- ing sites. Mol. Cell. Biol. 17:3714–3722. 2074 Defective NK Function in Stat5b-deficient Mice